西门子Healthineers报告第三季度业绩

2025-07-30 15:57

Siemens Healthineers AG press release (OTCPK:SEMHF): Q3 Non-GAAP EPS of €0.64.
Revenue of €5.66B (+4.4% Y/Y).
• Very strong comparable revenue growth of 7.6% • Imaging shows excellent comparable revenue growth of 11.7%; adjusted EBIT margin 21.0%
Diagnostics posts slight comparable revenue decline of 0.6%; adjusted EBIT margin 9.2%
Varian comparable revenue growth 8.7%; adjusted EBIT margin 18.8%
Advanced Therapies comparable revenue growth 4.5%; adjusted EBIT margin 10.5%
Overall adjusted EBIT margin 16.8%, clearly above prior-year quarter
Outlook: "We now expect comparable revenue growth of between 5.5% and 6% over fiscal year 2024 (previously between 5% and 6%) and adjusted basic earnings per share of between €2.30 and €2.45 (previously between €2.20 and €2.50),." the company said.

More on Siemens Healthineers AG